Juana María C. P.
- Country
- Spain
- Department
- Hematology
Research Overview
- Phase 1b Study of Loncastuximab Tesirine with Anti-cancer Agents in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
- A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY, VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1)
Data & Insights
Has run more than one trial at 8 of 79 partner sites.
Specializations
Lymphoma Research
This investigator specializes in treating patients with B-cell non-Hodgkin lymphoma, with particular expertise in managing refractory and relapsed cases. Their research encompasses innovative therapeutic approaches using novel antibody-drug combinations.
- Relapsed B-cell lymphoma treatment
- Refractory lymphoma management
- Combination therapy approaches
The investigator's work focuses on evaluating targeted therapies including loncastuximab tesirine in combination with other anti-cancer agents.
Targeted Therapy Development
Their research extends to the development and evaluation of novel targeted therapies, including odronextamab for previously untreated follicular lymphoma. The investigator studies comparative effectiveness against standard treatment regimens.
- Novel antibody therapeutics
- First-line treatment strategies
- Treatment response assessment
The research includes evaluation of safety profiles and therapeutic efficacy in various treatment-naive patient populations.
Clinical Assessment Methods
The investigator develops protocols for assessing treatment response and monitoring patient outcomes in lymphoma therapy. Their work includes evaluation of complete response rates and long-term efficacy measures.
- Response criteria development
- Safety monitoring protocols
- Long-term outcome assessment
Special attention is given to comparing novel therapeutic approaches with established treatment standards in lymphoma care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.